| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.3B | $81.4B | $78.6B | $79.6B | $80.1B | $20.3B | $11.9B | $11.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $23.5B | $20.8B | $21.3B | $21.6B | $20.2B | $18.9B | $14.1B | $13.2B |
| Operating Income | $18.3B | $18.0B | $14.3B | $6.5B | $6.9B | $1.7B | $1.2B | $1.1B |
| Net Income | $11.0B | $11.3B | $8.3B | $2.6B | $3.0B | $0.8B | $0.8B | $0.6B |
| EPS (Basic) | $9.75 | $9.70 | $7.02 | $2.07 | $2.42 | $0.60 | $0.88 | $0.75 |
| EPS (Diluted) | $9.72 | $9.66 | $6.93 | $2.06 | $2.41 | $0.60 | $0.87 | $0.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $219.2B | $208.0B | $207.7B | $211.3B | $206.6B | $200.2B | $86.9B | $72.5B |
| Current Assets | $24.5B | $18.4B | $19.0B | $19.1B | $20.9B | $23.9B | $9.3B | $8.3B |
| Cash & Equivalents | $5.6B | $5.4B | $5.1B | $4.5B | $6.6B | $10.4B | $1.5B | $1.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $24.5B | $20.2B | $20.9B | $24.7B | $23.5B | $21.7B | $12.5B | $10.3B |
| Stockholders' Equity | $59.2B | $61.7B | $64.7B | $69.7B | $69.1B | $65.3B | $28.8B | $24.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $27.9B | $22.3B | $18.6B | $16.8B | $13.9B | $8.6B | $6.8B | $3.9B |
| Investing Cash Flow | $-17.6B | $-9.1B | $-5.8B | $-12.4B | $-19.4B | $-12.7B | $-4.1B | $-0.6B |
| Capital Expenditures | $10.0B | $8.8B | $9.8B | $14.0B | $12.3B | $11.0B | $6.4B | $5.5B |
| Financing Cash Flow | $-10.1B | $-12.8B | $-12.1B | $-6.5B | $1.7B | $13.0B | $-2.4B | $-3.3B |